PTGX Free Cash Flow
$132.17MTTM · USD
Period ending:
PTGX FY Free Cash FlowUSD
$182.80M-$108.97M
2014-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
PTGX free cash flow history
Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.
| Period ending | Free Cash Flow (USD) |
|---|---|
| 56,081,000 | |
| 182,797,000 | |
| -70,845,000 | |
| -108,932,000 | |
| -108,966,000 | |
| -72,955,000 | |
| -42,494,000 | |
| -50,433,000 | |
| 3,206,000 | |
| -30,351,000 | |
| -14,784,000 | |
| -8,042,000 |
Compare free cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) free cash flow
- Bridgebio Pharma Inc (BBIO) free cash flow
- Brightspring Health Services Inc (BTSG) free cash flow
- Madrigal Pharmaceuticals Inc (MDGL) free cash flow
- Ensign Group Inc (ENSG) free cash flow
- Glaukos Corp (GKOS) free cash flow
- Vaxcyte Inc (PCVX) free cash flow
- Krystal Biotech Inc (KRYS) free cash flow
All PTGX financial metrics · PTGX stock overview · How to interpret financial metrics
